Vandetanib in a Child Affected by Neurofibromatosis Type 1 and Medullary Thyroid Carcinoma with Both NF1 and Homozygous RET Proto-oncogen Germ-line Mutations

Autor: Demir Gündoğan B; Mersin University Faculty of Medicine, Department of Pediatric Oncology, Mersin, Turkey, Sağcan F; Mersin University Faculty of Medicine, Department of Pediatric Oncology, Mersin, Turkey, Tuğ Bozdoğan S; Çukurova University Faculty of Medicine, Department of Medical Genetics, Adana, Turkey, Balcı Y; Mersin University Faculty of Medicine, Department of Radiology, Mersin, Turkey, Tuncel Daloğlu F; Mersin University Faculty of Medicine, Department of Pathology, Mersin, Turkey, Çağlar Çıtak E; Mersin University Faculty of Medicine, Department of Pediatric Oncology, Mersin, Turkey

Publikováno v: Journal of clinical research in pediatric endocrinology [J Clin Res Pediatr Endocrinol] 2021 Aug 23; Vol. 13 (3), pp. 342-346. Date of Electronic Publication: 2020 Jul 23.